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Cellular activation has long been considered a 
requirement for HIV infection of CD4 T cells, 
as HIV fails to infect resting CD4 T cells from 
peripheral blood. Infection is aborted either 
during reverse transcription (1) or before nuclear 
import of the viral preintegration complex (2). 
In contrast, recent studies show that resting 
CD4 T cells residing in tissue, analyzed either 
in vivo or ex vivo, are permissive for HIV in-
fection (3–6). Because the vast majority of CD4 
T cells are present in lymphoid tissues (7), most 
resting CD4 T cells are permissive for HIV in-
fection. Over half of all memory CD4 T cells 
are infected and killed during acute simian 
  immunodefi  ciency virus (SIV) infection in rhe-
sus macaques (4, 8). Similarly, during acute 
SIV/HIV chimeric virus infection, resting naive 
CD4 T cells are a principal target for infection 
and emerge as primary virus-producing cells 
(6). The molecular mechanisms underlying the 
permissivity diff  erences between resting CD4 
T cells in tissue and blood remain unknown.
Ex vivo lymphoid cultures are an attractive 
system to address this question, as resting CD4 
T cells, both naive and memory, are permissive 
to HIV infection independent of exogenous 
stimuli (3). Although well-recognized for 
memory CD4 T cells (9, 10), HIV infection of 
naive CD4 T cells was not fully appreciated 
until recently. In some studies, naive CD4 T 
cells from peripheral blood are refractory to 
HIV infection in vitro (11, 12), but the physio-
logical relevance of this fi  nding is uncertain 
  because circulating HIV-infected naive CD4 
T cells are detectable in vivo (13, 14).
The antiviral factor APOBEC3G (A3G) 
plays a key role in regulating the permissivity 
of CD4 T cells to HIV infection. Recently, we 
reported that resting CD4 T cells in peripheral 
blood are protected from HIV infection 
through the action of low molecular mass 
(LMM) A3G (15). Small interfering RNA–
  mediated knock down of A3G expression ren-
dered these cells permissive to infection, as did 
stimulation with mitogens that promoted the 
recruitment of LMM A3G into inactive high 
molecular mass (HMM) A3G ribonucleo-
protein complexes. These fi  ndings raised the 
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Human immunodefi  ciency virus (HIV) can infect resting CD4 T cells residing in lymphoid 
tissues but not those circulating in peripheral blood. The molecular mechanisms producing 
this difference remain unknown. We explored the potential role of the tissue microenviron-
ment and its infl  uence on the action of the antiviral factor APOBEC3G (A3G) in regulating 
permissivity to HIV infection. We found that endogenous IL-2 and -15 play a key role in 
rendering resident naive CD4 T cells susceptible to HIV infection. Infection of memory CD4 
T cells also requires endogenous soluble factors, but not IL-2 or -15. A3G is found in a high 
molecular mass complex in HIV infection–permissive, tissue-resident naive CD4 T cells but 
resides in a low molecular mass form in nonpermissive, blood-derived naive CD4 T cells. 
Upon treatment with endogenous soluble factors, these cells become permissive for HIV 
infection, as low molecular mass A3G is induced to assemble into high molecular mass 
complexes. These fi  ndings suggest that in lymphoid tissues, endogenous soluble factors, 
likely including IL-2 and -15 and others, stimulate the formation of high molecular mass 
A3G complexes in tissue-resident naive CD4 T cells, thereby relieving the potent postentry 
restriction block for HIV infection conferred by low molecular mass A3G.
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possibility that in HIV-permissive, resting CD4 T cells from 
tissue, A3G might be present in HMM complexes. In this 
study, we used lymphoid organ cultures to explore this 
  possibility and the role of the tissue microenvironment in 
regulating HIV permissivity of these cells.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
Soluble factors in HLAC-conditioned medium render 
tissue-derived naive CD4 T cells permissive to HIV infection
We fi  rst sought to identify the mechanisms underlying the 
permissivity of naive CD4 T cells in lymphoid tissues. To 
determine whether cell–cell contact or soluble factors pro-
duced in lymphoid tissue are required for HIV infection of 
tissue-resident naive CD4 T cells, these cells were purifi  ed 
from human lymphoid aggregate cultures (HLACs) prepared 
from human tonsils (3, 16) and tested under diff  erent culture 
conditions. Infected cells were identifi  ed by intracellular Gag 
(anti-p24) immunostaining and fl   ow cytometric analysis. 
  Naive CD4 T cells cultured in isolation in medium alone 
could not be infected by HIV (Fig. 1, left). However, when 
the cells were returned to autologous HLACs, HIV infectiv-
ity was restored (Fig. 1, middle). To determine whether 
  endogenously produced soluble factors contributed to the 
  acquisition of HIV permissivity, the cells were cultured in 
HLAC-conditioned medium. Again, the cells became per-
missive for HIV infection (Fig. 1, right). Addition of azido-
thymidine (AZT) blocked detection of intracellular Gag 
immunostaining, demonstrating that this signal was depen-
dent on de novo reverse transcription. Of note, the viability 
of naive CD4 T cells in these cultures was comparable 
  (unpublished data), suggesting that the infection results refl  ect 
diff  erences in their state of permissivity rather than overall 
health. In addition, the activation status of both cultures was 
similar; each contained a small percentage of cells expressing 
either CD25 or CD69, typical for tissue-resident naive CD4 
T cells (unpublished data).
These results are consistent with those of Kinter et al. (17), 
who showed that isolated tissue-derived CD4 T cells are per-
missive upon return to HLAC but not when cultured alone. 
Our work extends these studies by showing that permissivity of 
tissue-derived naive CD4 T cells can be conferred by HLAC-
conditioned medium, suggesting a role for soluble factors.
IL-2 and -15 are necessary but not suffi  cient components 
of the permissivity activity in conditioned medium
To identify the factors present in conditioned medium neces-
sary to render tissue-derived naive CD4 T cells permissive, 
we considered the study by Unutmaz et al. (18), which 
showed that 10–20 ng/ml IL-2, -4, -7, or -15 rendered other-
wise unstimulated blood-derived CD4 T cells susceptible to 
HIV infection. Consistent with this and other studies (19, 20), 
we found that addition of 20 ng/ml IL-2, -4, -7, or -15 was 
Figure 1.  Conditioned medium from HLAC renders tissue-derived 
naive CD4 T cells permissive to HIV infection. Cells were cultured in 
medium alone (left), labeled with CFSE, and mixed back with autologous 
HLAC (middle) or were cultured in HLAC-conditioned medium (right). 
Intracellular anti–p24-Gag staining was performed 7 d after infection 
with NL4-3 (150 ng of p24-Gag). 50 μM AZT was included in some sam-
ples to ensure identifi  cation of productively infected cells (bottom). Data 
are representative of three experiments in which typically 5–10% of cells 
cultured in conditioned medium stained positively for intracellular Gag 
at the peak of infection.
Figure 2.  IL-2 and -15 are necessary but not suffi  cient compo-
nents in conditioned medium for HIV infection of tissue-derived 
naive CD4 T cells. (A) Cells were cultured in medium alone, conditioned 
medium, or conditioned medium previously incubated with anti–IL-2, 
anti–IL-7, or anti–IL-15 capture antibodies and inoculated with NL4-3 
(150 ng of p24-Gag). After extensive washing, virus-containing superna-
tants were monitored for p24-Gag content after 4, 7, 10, or 13 d of cul-
ture. Select cultures were treated with 50 μM AZT as a control. (B) Cells 
were cultured in medium with or without IL-2 or -15 (5, 50, or 500 pg/ml). 
One sample was cultured with IL-2 and -15 (5 pg/ml). Cells were   infected 
as described in A. p24-Gag was measured by FLAQ assay. Data are 
  representative of three independent experiments.JEM VOL. 203, April 17, 2006  867
BRIEF DEFINITIVE REPORT
suffi   cient for tissue-derived naive CD4 T cells to sustain a 
spreading infection (unpublished data).
We next examined whether depletion of select cytokines 
from the conditioned medium altered rescue of HIV per-
missivity in tissue-derived naive CD4 T cells. IL-2 and -15, 
  present at 5–10 and 2–5 pg/ml, respectively, were depleted 
from the conditioned medium by treatment with capture an-
tibodies bound to insoluble bead supports. This procedure 
eff   ectively reduced these cytokines to undetectable levels 
(unpublished data). To control for nonspecifi  c inhibition by 
the depletion procedure, beads bound with antibodies recog-
nizing IL-7 were also used, as IL-7 was undetectable in the 
conditioned medium. Depletion of either IL-2 or -15 mark-
edly reduced the ability of the conditioned medium to rescue 
viral replication; however, as expected, depletion with anti-
bodies recognizing IL-7 had no eff  ect (Fig. 2 A). Further 
supporting a necessary role for IL-2, addition of a blocking 
antibody specifi  c for the α chain of the high-affi   nity IL-2 
  receptor also inhibited viral replication, whereas a control 
  antibody against the IL-4R did not (unpublished data).
Next, we tested whether the addition of recombinant 
IL-2 or -15 at levels found in conditioned medium was suffi   -
cient to render tissue-derived naive CD4 T cells permissive. 
By comparison, these experiments were performed with doses 
99.999% lower than those previously tested by Unutmaz 
et al. (18). At 5 pg/ml, IL-2 and -15 alone or in combination 
were not suffi   cient to promote infection of tissue-derived na-
ive CD4 T cells (Fig. 2 B). Similarly, the combination of IL-2 
and -15 at 20 pg/ml was ineff  ective (not depicted). At 500 
pg/ml, IL-2 and -15 each conferred permissivity (Fig. 2 B). 
Thus, the endogenous levels of IL-2 and -15 are necessary 
but probably not suffi   cient for the permissivity activity found 
in conditioned medium.
Other examples of paracrine signaling conferring permis-
sivity to HIV infection have been described. Using cultures 
from peripheral blood, Swingler et al. (21) found that HIV-
infected or activated macrophages produce soluble CD23 
and soluble ICAM (intercellular adhesion molecule), which 
act on B cells to render T cells permissive by cell–cell con-
tacts. As IL-2 and -15 act directly on purifi  ed naive CD4 
T cells, eff  ects on intermediate cells do not appear to be in-
volved. Others have highlighted a role for paracrine signaling 
by certain proinfl  ammatory cytokines. Endogenous IL-1β, 
IL-6, and TNF-α are necessary for HIV infection in subopti-
mally stimulated PBMCs (22, 23). In ex vivo lymphoid cul-
tures, neutralization of endogenous IL-1β or -6 decreases HIV 
replication when the tissue is cultured on collagen rafts but 
not when dispersed in HLAC (16). Because HIV replication 
in HLAC is unaff  ected by neutralization of these cytokines, 
it is unclear what role, if any, they play in regulating the 
  permissivity of tissue-derived naive CD4 T cells.
Soluble factors render tissue-derived memory CD4 T cells 
permissive to HIV infection
Next, we investigated the role of IL-2, IL-15, and other 
  soluble factors in HIV infection of memory CD4 T cells. As 
tissue-resident memory CD4 T cells are a major target for 
HIV infection in vivo (4, 5, 8), understanding the molecular 
basis for permissivity in these cells could advance our under-
standing of HIV pathogenesis. Like tissue-derived naive CD4 
T cells, tissue-derived memory CD4 T cells were refractory 
to HIV infection unless cultured in the presence of condi-
tioned medium (Fig. 3). Surprisingly, conditioned medium 
depleted with antibodies specifi  c for IL-2, -4, -7, and -15 
  retained the ability to render the memory CD4 T cells per-
missive to infection (Fig. 3). As expected, the depleted 
  conditioned medium did not confer permissivity on tissue-
derived naive CD4 T cells (unpublished data). Thus, memory 
CD4 T cells in lymphoid tissue appear to acquire permissivity 
for HIV infection through soluble factors diff  erent from those 
that confer permissivity on naive CD4 T cells.
Naive CD4 T cells in the absence of conditioned medium 
exhibit an early postentry block to HIV infection
To determine whether conditioned medium alters the abil-
ity of tissue-derived naive CD4 T cells to support HIV 
env–  mediated entry, we used a virion-based fusion assay (24). 
Equivalent levels of fusion were observed in the presence and 
absence of conditioned medium (Fig. 4 A), consistent with 
an eff  ect occurring after virion fusion.
If conditioned medium aff  ects early postentry steps in the 
viral life cycle, cells cultured in the absence of conditioned 
medium would be refractory to infection with single-cycle 
reporter viruses. However, if the block occurs after integra-
tion and gene expression, cells should be permissive in the 
presence or absence of conditioned medium. In tissue-
  derived naive CD4 T cells exposed to a single-cycle reporter 
virus, vesicular stomatitis virus G (VSV-G)–pseudotyped 
NL4-3 heat-stable antigen (HSA), reporter gene expression 
was detected only in the presence of conditioned medium 
Figure 3.  Infection of tissue-derived memory CD4 T cells also 
  requires soluble factors. Tissue-derived memory CD4 T cells were 
  cultured in medium alone, conditioned medium, or conditioned medium 
previously incubated with anti–IL-2, anti–IL-4, anti–IL-7, and anti–IL-15 
capture antibodies. Cultures were inoculated with NL4-3 (150 ng of 
p24-Gag); after extensive washing, virus-containing supernatants were 
  monitored for p24-Gag content after 4, 7, 10, or 13 d of culture. Select 
cultures were treated with 50 μM AZT as a control. p24-Gag was 
  measured by FLAQ assay. The depleted conditioned medium failed to 
  support HIV replication in tissue-derived naive CD4 T cells from the same 
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(Fig. 4 B). Thus, conditioned medium appears to overcome 
an early postentry block to HIV infection in tissue-derived 
naive CD4 T cells.
Naive CD4 T cells contain HMM A3G when isolated 
from tonsil or when cultured in conditioned medium
The early block to HIV infection in the absence of condi-
tioned medium is reminiscent of the block observed in un-
stimulated CD4 T cells in peripheral blood (1, 2), which we 
have shown are protected from HIV infection by expression 
of LMM A3G (15). If LMM A3G is eliminated by small in-
terfering RNA treatment or is converted to an HMM com-
plex by mitogenic stimulation, these cells are rendered 
permissive. To determine whether HMM A3G is present in 
tissue-resident, HIV-permissive CD4 T cells, we used veloc-
ity sedimentation analysis to compare A3G complexes in 
  purifi  ed naive CD4 T cells from peripheral blood or tonsil 
(Fig. 5 A). In these gradients, HMM A3G accumulated near the 
bottom, whereas LMM A3G sedimented near the middle, 
similar in size to tubulin (unpublished data). In blood-derived 
naive CD4 T cells, A3G was in the LMM form, consistent 
with results in unfractionated CD4 T cells (15). In naive CD4 
T cells from tonsil tissue, A3G was detected principally in the 
HMM form, consistent with the permissivity of these cells to 
HIV infection (3). Similar results were obtained when A3G 
complexes were analyzed in purifi  ed CD4 T cells from either 
peripheral blood or tissue by size-exclusion chromatography 
(unpublished data), as described by Chiu et al. (15).
These fi  ndings suggest that conditioned medium might 
render cells permissive to HIV infection by promoting the 
assembly of HMM A3G complexes. As it was diffi   cult to 
  purify enough naive CD4 T cells from tissue for the needed 
biochemical analysis, experiments were instead performed 
using cells isolated from the peripheral blood. When cul-
tured in conditioned medium but not medium alone, 1–3% 
of cells became permissive, as measured by single-cycle infec-
tion with HSA-reporter viruses (unpublished data). This 
fi  nding is consistent with the small number of cells express-
ing CD25 in the conditioned medium–treated cultures 
  (unpublished data), indicating low levels of activation. As 
permissive cells are rare, a highly sensitive biochemical tech-
nique must be used to analyze the A3G complexes present in 
these cultures. In this regard, size-exclusion chromatography 
is preferable to the velocity sedimentation gradients used 
earlier. When naive CD4 T cells from the peripheral blood 
Figure 4.  Conditioned medium relieves an early postentry block 
of HIV infection in tissue-derived naive CD4 T cells. (A) Cells cultured 
in medium alone or conditioned medium were exposed to NL4-3 virions 
(250 ng of p24-Gag) containing BlaM-Vpr for 2 h before performing the 
virion-based fusion assay (reference 24). As a negative control, 250 nM of 
AMD3100, an inhibitor of CXCR4-mediated entry, was included. Data are 
representative of three experiments, during which levels of fusion ranged 
from 5 to 12% in the cell population. (B) Cells were exposed to VSV-G–
pseudotyped NL4-3 HSA R-E- (700 ng of p24-Gag) for 3 h, washed 
  extensively, and stained for surface expression of HSA 4 d later. Select 
cultures were treated with 10 μM 3TC as a control. Similar results were 
obtained in four additional experiments, with levels of HSA infection 
ranging from 0.7 to 4.0% in the cell population.
Figure 5.  Naive CD4 T cells contain HMM A3G when isolated from 
tonsil or when blood-derived cells are cultured in conditioned 
  medium. (A) Lysates of naive CD4 T cells from peripheral blood or tonsil 
were subjected to velocity sedimentation analysis. Equal volumes of 
collected fractions were subjected to SDS-PAGE and immunoblotting for 
endogenous A3G using a peptide-specifi  c rabbit anti-hA3G antibody 
  (reference 26). Comparable data were obtained in two additional 
  experiments. (B) FPLC analysis was performed on lysates of blood-derived 
naive CD4 T cells that were cultured for 6 d in medium alone or condi-
tioned medium. Fractions were concentrated 10-fold before immunoblot 
analysis. These results are representative of three independent experiments.JEM VOL. 203, April 17, 2006  869
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were cultured in medium alone, A3G remained in LMM 
complexes (Fig. 5 B). In contrast, when cultured in condi-
tioned medium, both the levels of A3G increased (unpub-
lished data) and, importantly, a fraction of the LMM A3G 
was recruited into HMM complexes (Fig. 5 B). It is likely 
that the modest shift of A3G into these HMM complexes 
refl  ects a response occurring in the small percentage of cells 
that are permissive for HIV infection, although direct proof 
of such a fractional cellular response is lacking. Given the 
clear but modest ability of soluble factors alone to drive 
HMM complex formation and the high levels of HMM A3G 
present in cells isolated directly from tissue, it is possible that 
the assembly of A3G complexes in vivo is regulated by both 
soluble factors and cell–cell contacts.
In summary, our fi  ndings show that endogenously pro-
duced IL-2 and -15 play an important role in rendering 
  tissue-resident resting, naive CD4 T cells permissive to HIV 
infection. Investigation is currently under way to identify 
other soluble factors that contribute to infection of both na-
ive and memory CD4 T cells. In terms of the molecular basis 
underlying permissivity of tissue-resident naive CD4 T cells 
to HIV infection, these cells display enzymatically inactive 
HMM A3G complexes, whereas nonpermissive naive CD4 
T cells from peripheral blood contain LMM A3G, which 
functions as a potent postentry restriction factor (15). Fur-
ther, the addition of HLAC-conditioned medium to resting 
naive CD4 T cells from the peripheral blood is suffi   cient to 
induce modest recruitment of LMM A3G into HMM com-
plexes when measured across the entire population. We sus-
pect that HMM A3G complex assembly actually occurs only 
within the small subset of the cells that are permissive to HIV 
infection in single-cycle infection experiments. Because the 
vast majority of CD4 T cells reside in tissues (7), our fi  ndings 
help explain how massive numbers of resting CD4 T cells can 
be infected and depleted during acute lentiviral infections (4, 8) 
while circulating resting CD4 T cells remain entirely refrac-
tory to HIV infection (1, 2).
MATERIALS AND METHODS
HLAC and conditioned medium. Human tonsil tissue from routine ton-
sillectomies was obtained from the National Disease Research Interchange 
and the Cooperative Human Tissue Network and processed for HLAC as 
described previously (3, 16). In brief, tonsils were minced, passed through a 
40-μm cell strainer, and cultured in 96-well U-bottomed polystyrene plates 
(2 × 106 cells/well) in medium (200 μl/well) consisting of RPMI 1640 sup-
plemented with 15% FCS, 100 μg/ml gentamicin, 200 μg/ml ampicillin, 
1 mM sodium pyruvate, 1% nonessential amino acids (Mediatech), 2 mM 
l-glutamine, and 1% fungizone (Invitrogen). After 2–4 d of culture, condi-
tioned medium was collected and passed through a 0.2-μm nylon fi  lter. 
Before use, conditioned medium was mixed with an equal volume of fresh 
medium to ensure an adequate supply of nutrients and neutral pH.
Cytokine depletion, receptor blocking, and quantitation of condi-
tioned medium. Cytokines were depleted from conditioned medium with 
capture antibodies specifi  c for IL-2, -4, -7, and -15 (MAB602, -604, -207, 
and -647; R&D Systems). The antibodies were bound to insoluble bead sup-
ports (Seize X protein G immunoprecipitation kit; Pierce Chemical Co.) 
and incubated with the conditioned medium for 4 h at room temperature 
with constant agitation. The cytokine-depleted conditioned medium was 
collected after sedimentation of the antibody-containing beads. Blocking 
antibodies specifi  c  for  IL-2Rα (2 μg/ml AF-223-NA; R&D Systems) 
or IL-4R (5 μg/ml MAB230; R&D Systems) were used to inhibit receptor 
binding. Cytokine levels in conditioned medium were quantitated by 
ELISA (sensitivity: IL-2, 1.6 pg/ml; IL-7, 0.156 pg/ml; IL-15, 0.3 pg/ml; 
R&D Systems).
Purifi  cation of naive and memory CD4 T cells. Naive and memory 
CD4 T cells in buff  y coats (Stanford Blood Bank) or HLAC were fi  rst 
  enriched by Ficoll-Hypaque density gradient separation of mononuclear 
cells. These cells were then sorted for either CD4+ CD45RA+ CD62L+ 
(naive) or CD4+ CD45RA− (memory) using a FACS DiVa (BD Biosciences). 
  Alternatively, naive cells were isolated from mononuclear cells by magnetic 
negative depletion (naive CD4 T cell isolation kit; Miltenyi Biotec) supple-
mented with microbeads against CD8, -14, -19, and -45RO. Purity was 
routinely >95% by fl  ow cytometry and >90% using microbeads. After iso-
lation, naive or memory CD4 T cells from tissue (1–2 × 105 in 96-well 
U-bottomed polystyrene plates) or from peripheral blood (2 × 106/ml in 
6-well polystyrene plates) were cultured with medium alone, medium sup-
plemented with recombinant IL-2 or -15 (R&D Systems), or conditioned 
medium. For experiments requiring CFSE labeling, 5 × 106/ml cells were 
washed once with PBS and incubated with 1 μM CFSE (Invitrogen) in PBS 
for 5 min at room temperature. To quench the labeling reaction, cells were 
washed in fresh medium.
HIV viral stocks. The proviral expression plasmids pNL4-3 (M. Martin, 
National Institute of Allergy and Infectious Diseases [NIAID], Bethesda, MD) 
and pNLS4-3 HSA R-E- (N. Landau, The Salk Institute, La Jolla, CA) were 
obtained from the AIDS Research and Reference Reagent Program, Division 
of AIDS, at NIAID. The expression plasmid pVSV-G was obtained from 
J. Burns (University of California, San Diego, La Jolla, CA). Replication-
  competent NL4-3 (X4-tropic) and VSV-G–pseudotyped reporter virus 
(NL4-3 HSA R-E-) encoding HSA (mouse CD24) were prepared by calcium 
phosphate transfection of 293T cells. Virus-containing supernatants were 
  collected 48 h later, clarifi  ed by sedimentation, fi  ltered, and concentrated by 
  ultracentrifugation. For fusion studies, NL4-3 virions containing BlaM-Vpr 
were prepared as described previously (24). All viral stocks were quantitated 
by measuring p24-Gag levels by ELISA (PerkinElmer) or FLAQ (25).
Viral infections. For spreading infections, cells were cultured with or 
without a reverse transcriptase inhibitor (50 μM AZT) for 24 h, incubated 
with NL4-3 (150 ng of p24-Gag) for 24 h, washed extensively, and cultured. 
The medium was replaced every 3 d. For single-cycle infections, cells were 
cultured with or without a reverse transcriptase inhibitor (10 μM 3TC) for 
48 h, inoculated with VSV-G–pseudotyped NL4-3 HSA R-E- (200–1,000 ng 
of p24-Gag) in the presence of 5 μg/ml polybrene for 3 h, washed exten-
sively, and returned to culture. For virion-based fusion assays, cells were 
  incubated with NL4-3 virions containing BlaM-Vpr (250 ng of p24-Gag) 
for 2 h, and assays were performed as described previously (24). Negative 
controls were pretreated with a CXCR4-specifi  c entry inhibitor (250 nM 
AMD3100), obtained from D. Schols (Katholieke Universiteit Leuven, 
  Leuven, Belgium).
FACS analysis of HIV-infected cultures. For intracellular anti–p24-Gag 
immunostaining, cells were fi  xed in 1% paraformaldehyde and stained with 
an anti–p24-Gag antibody (KC57; Beckman Coulter) in PBS containing 0.1% 
saponin (Sigma-Aldrich) and 2% FBS. To measure surface expression of HSA, 
cells were stained with anti-HSA antibody (M1/69; BD Biosciences) in 
PBS containing 2% FBS. FACS data were analyzed with FlowJo software 
(Treestar). For the fusion assay, the levels of virion fusion are shown as a ratio 
of blue/green fl  uorescence refl  ecting the presence of cleaved versus uncleaved 
CCF2 substrate, with the former refl  ecting fusion (24).
Characterization of A3G complexes. Linear, continuous 15–30% glyc-
erol gradients were prepared in buff  er containing 50 mM Hepes, pH 7.4, 870  HIV INFECTION OF NAIVE CD4 T CELLS IN LYMPHOID TISSUE | Kreisberg et al.
125 mM NaCl, and 0.1% NP-40. Naive CD4 T cells were lysed in ice-cold 
lysis buff  er containing 50 mM Hepes, pH 7.4, 125 mM NaCl, 0.2% NP-40, 
and 1 × EDTA-free protease inhibitor cocktail (Calbiochem). The clarifi  ed 
cell lysates were loaded on the gradients and centrifuged at 130,000 g for 
16 h at 4°C in an SW55Ti rotor (Beckman Coulter). After sedimentation, 
22 fractions (each  210 μl) were collected from the bottom to the top of the 
gradient. Fast protein liquid chromatography (FPLC) analysis was performed 
as described previously (15) except that because of the limited amount of 
material, FPLC fractions were concentrated 10-fold (Microcon YM-30; 
Millipore) before detection of A3G by immunoblot analysis. To prevent 
nonspecifi  c loss of sample during concentration, 50–100 μg of glutathione 
reductase (Sigma-Aldrich) were added to each fraction.
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